14 results
8-K
EX-99.3
elotbqb
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
EX-99.1
xdwbx4b3uxnyf7l jrwh
24 Jul 23
Corporate Presentation July 2023
6:43am
425
EX-99.1
5ncibdzy 0px17
23 May 23
Business combination disclosure
9:39pm
8-K
EX-99.1
nu6lznx ppz
23 May 23
Corporate Presentation May 2023
9:38pm
S-4
EX-10.13
h2drl ca7eb7a
23 Dec 22
Registration of securities issued in business combination transactions
6:28pm
8-K
EX-1.1
hf6quo5p24to 8ha7
12 Feb 21
Priveterra Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering
4:31pm
- Prev
- 1
- Next